Growth Hormone Resistance of Beta-cells A

Part of paid clinical trials in Columbia, Missouri.

Sponsor
University of Missouri-Columbia
Study ID
NCT06571487
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 45 Years
Healthy Volunteers
Accepted

Study Details

The purpose of the research study is to better understand how beta-cells (cells in the pancreas that make insulin and help regulate blood sugar) respond to growth hormone in people with a personal history of gestational diabetes (high blood sugar in pregnancy) at the University of Missouri. The aim of the study is to advance understanding of how growth hormone affects beta-cells and risk factors for developing gestational diabetes.

Key Dates

Start date
Oct 22, 2025
Status verified
Apr 2026
Primary completion
Sep 1, 2028
Completion
Sep 1, 2030

Study Design

Enrollment
30 participants (estimated)

Arms

  • Arm: Women with a history of gestational diabetes mellitus
  • Arm: Women without a history of gestational diabetes mellitus

Primary Outcome Measure

Beta-cell function [ Time Frame: before and 7 days after rhGH administration ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Missouri School of MedicineColumbiaMissouri65212
Bettina Mittendorfer
[email protected]
573-882-9377

Find similar trials in Columbia, MO

By condition
Obesity / overweight
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
University of Missouri School of Medicine· Columbia, MO

Related Studies